Marijuana Stocks & Publicly Traded Cannabis Companies

Senator raises specter of recreational cannabis legalization delay in Canada

Canada’s recreational marijuana industry might not be up and running until the end of 2018, an opposition senator has indicated, raising the specter of a months-long delay that would have major ramifications for businesses up and down the cannabis supply chain. “The costs of missing that deadline would be severe,” according to The Globe and […]

Read More

Manitoba’s Delta 9 strikes deal to raise CA$20M for cannabis cultivation and retail

Delta 9 signed a stock-purchase agreement to raise 20 million Canadian dollars ($16 million) to ramp up cultivation and bankroll its bid to become a retailer of recreational marijuana in Manitoba. The Winnipeg, Manitoba-based medical marijuana producer said in a news release it nailed down the bought-deal agreement with a group of underwriters led by […]

Read More

Canada’s largest pharmacy chain inks ‘game-changing’ medical marijuana distribution deal

Medical marijuana could soon be available through the online store of Canada’s largest pharmacy chain in what analysts are calling a groundbreaking deal for the MMJ industry. Aphria is set to supply the medical cannabis, including leaf and oil, for Toronto-based Shoppers Drug Mart. The Ontario-based licensed producer will be designated as the “preferred” supplier […]

Read More

Canada’s Maricann looks to sell medical marijuana in German pharmacies

Ontario-based Maricann expects to start shipping dry cannabis flower to Germany in early 2018, making it the latest Canadian company to export medical marijuana to what could soon become the world’s largest MMJ market. The company’s German subsidiary, Maricann GmbH, also applied for a license to import Maricann’s cannabis from Canada with the intention of distributing […]

Read More

Aurora Cannabis goes on ambitious buying spree

Cash-rich Aurora Cannabis is steamrolling ahead with its aggressive domestic and international expansion plans, snapping up a leading international greenhouse design company and a late-stage marijuana production applicant in Quebec. Those deals came days after Aurora commenced a hostile takeover attempt of rival producer CanniMed Therapeutics in what could be the largest takeover in the industry […]

Read More

Canadian cannabis company to pay $1.6M for California dispensary

A Canadian marijuana company has entered into an agreement to buy a privately owned medical cannabis dispensary in California for $1.6 million (CA$2 million), the latest sign that interest in American MJ assets is slowly picking up in Canada. British Columbia-based Marapharm put down a cash deposit of $160,000 for Green Leaf Wellness in Desert Hot […]

Read More

New rules would have major impact on most Canadian cannabis businesses

A new set of regulatory proposals has been released by Health Canada that would have wide-ranging implications for most businesses in Canada’s marijuana industry — and even many stuck in the gray market. The regulations would facilitate the coming into force of the Cannabis Act – which is still subject to parliamentary approval – and […]

Read More

TerrAscend announces CA$52 million financing, Canopy partnership

A Mississauga, Ontario-based medical marijuana company is taking steps to raise 50 million Canadian dollars ($40 million) through a private placement of its securities to expand its existing facility and pursue strategic pharmaceutical assets. TerrAscend – traded on the Canadian Securities Exchange under the symbol TER – said in a news release that it entered […]

Read More

Ex-MassRoots CEO makes move to oust board, current leadership

MassRoots founder and former CEO Isaac Dietrich on Monday filed paperwork with federal regulators to call for a special meeting and new shareholder vote, an attempt to force his way back into the company and dethrone the other board members who fired him last month. Dietrich – who owns 15.82% of the company’s outstanding stock […]

Read More

Aurora to raise additional CA$100M for domestic, global growth

Aurora Cannabis has arranged a private placement of its securities to raise another 100 million Canadian dollars ($80 million), giving the Alberta producer a cash cushion totaling more than CA$340 million. The deal comes just two days after Aurora offered to acquire rival producer CanniMed Therapeutics for CA$544 million ($425 million) in stock. It’s unclear […]

Read More